C&S Partners advises Dr. Lal Ventures on acquiring 30% stake in Neuome Technologies

The stake acquisition was made by way of subscription of shares.

Bar & Bench

Published:22nd Sep, 2026 at 6:02 PM

Dr. Lal Ventures Private Limited, a wholly owned subsidiary of Dr. Lal PathLabs Limited, has acquired a 30% stake in Neuome Technologies Private Limited, by way of subscription of shares.

C&S Partners advised Dr. Lal Ventures on this transaction.

The transaction team consisted of Saurabh Tiwari (Partner), Anant Garg (Partner), Arya Sharma (Associate) and Abhijeet Kumar (Associate).

Neuome Technologies is engaged in developing advanced technologies for biospecimen collection & storage and advanced diagnostic tools.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

SCROLL FOR NEXT

C&S Partners advises Dr. Lal Ventures on acquiring 30% stake in Neuome Technologies

The stake acquisition was made by way of subscription of shares.

Also Read

Bombay High Court quashes Customs order flagged for citing non-existent AI-generated judgments

Outraging modesty provision under BNS applies to transgender women: Bombay High Court

NMC founder BR Shetty held liable for $5.4 billion healthcare fraud by Abu Dhabi court

ED is not super cop: Karnataka High Court quashes money laundering probe against Congress leader

Delhi High Court grants bail to 2 doctors in ₹842 crore DGHS procurement case